Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan hemodynamic effects in heart failure
NCT00132886Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Dec 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tolvaptan in heart failure (HF), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Dec 2004; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00132886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132886.